Abstract
Five patients with gonadotropin-secreting pituitary adenomas were studied. The utility of gonadotropin response to TRH stimulation in the diagnosis and follow-up of these tumors was evaluated, as well as the effects of somatostatin analogue SMS 201–995 and bromocriptine on gonadotropin release. Three patients had FSH and LH secreting adenomas while the other two tumors secreted FSH and a-subunit. Transsphenoidal resection of the pituitary adenomas were performed in all patients. Following preoperative TRH administration (400 μg iv), marked increases were observed in FSH levels in two cases, in LH levels in three and in α-subunit in one. The FSH and LH responses to this stimulus persisted in the same patients after surgery. Following acute bromocriptine administration (5 mg orally), FSH was reduced in all cases by 19% to 46%; LH in three cases by 50–67% and α-subunit in one by 33%. In patient no. 5, with persistent high FSH levels in the immedi.ate postoperative period, long-term bromocriptine treatment was administered (15 mg/d orally), resulting in normalization of FSH levels 6 months later, although the size of the tumor was not reduced. After acute SMS 201–995 administration (100 μg sc) FSH decreased in two cases by 38% and 76%, LH in three by 30–56% and a-subunit in one by 20%. We conclude that gonadotropin response to TRH stimulation is useful in the diagnosis and follow-up of patients with gonadotroph adenoma. Bromocriptine and SMS 201–995 may be effective as coadjuvant treatment following surgery and radiotherapy in these patients, although long-term studies will be necessary to confirm these proposals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Snyder P.J. Gonadotroph cell adenomas of the pituitary. Endocr. Rev. 6: 552, 1985.
Horvath E., Kovacs K. Gonadotroph adenomas of the human pituitary: structural dichotomy. Am. J. Pathol. 117: 429, 1984.
Beckers A., Stevenaert A., Mashiter K., Hennen G. Follicle-stimulating hormone secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 61: 525, 1985.
Kwekkeboom D.J., De Jong F.H., Lamberts S.W.J. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. J. Clin. Endocrinol. Metab. 68: 1128, 1989.
Black P., Hsu D., Klibanski A., Kliman B., Jameson J.L., Ridgway EC, Hedle-Whyte T., Zervas N.T. Hormone production in clinically nonfunctioning pituitary adenomas. J. Neurosurg. 66: 244, 1987.
Oppenheim D.S., Klibanski A. Medical therapy of glycoprotein hormone-secreting pituitary tumors. Endocrinol. Metab. Clin. North. Am. 18: 339, 1984.
Daneshdoost L., Aldrich T.K., Prezant D.J., Sinnett M.J., Enden J.B., Williams M.H. Recognition of gonadotroph adenomas in women. N. Engl. J. Med. 324: 589, 1991.
Molitch M.E. Gonadotroph-cell pituitary adenomas. N. Engl. J. Med. 324: 626, 1991.
Klibanski A., Zervas N.T. Diagnosis and management of hormone secreting pituitary adenomas. N. Engl. J. Med. 324: 822, 1991.
Berezin M., Olchovsky D., Pines A., Tadmor R., Lunenfeld B. Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine. J. Clin. Endocrinol. Metab. 59: 1220, 1984.
Vance M.L., Ridgway E.C., Thorner M.O. Follicle-stimulating hormone and α-subunit-secreting pituitary tumor treated with bromocriptine. J. Clin. Endocrinol. Metab. 61: 580, 1985.
Chapman A.J., McFarlane I.A., Shalet S.M., Beardwell C.G., Dutton J., Sutton M.L. Discordant serum α-subunit and FSH concentrations in a woman with a pituitary tumor. Clin. Endocrinol. (Oxf.) 21: 123, 1984.
Klibanski A., Deutsch P.J., Jameson J.L., Ridgway E.C., Crowley W.F., Hsu D.W., Habener J.F., Black P. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and and clinical studies. J. Clin. Endocrinol. Metab. 64: 536, 1987.
Lamberts S.W.J., Verleun T., Oosterom R., Hofland L., van Ginkel L.A., Loeber J.G., van Vroonhoven C.C.J., Stepanko S.Z., de Jong F.M. The effects of bromocriptine, thyrotropin-releasing hormone and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. J. Clin. Endocrinol. Metab. 64: 524, 1987.
McFarlane I.A., Beardwell C.G., Shalet S.M., Ainslie G., Rankin E. Glycoprotein hormone α-subunit secretion in patients with pituitary adenomas: influence of TRH, LRH and bromocriptine. Acta Endocrinol. (Copenh) 99: 487, 1982.
Vos P., Croughs R.J.M., Thijssen J.H.H., van’t Verlaat, van Ginkel L.A. Response of luteinizing hormone secreting pituitary adenoma to a long-acting somatostatin analogue. Acta Endocrinol. (Copenh.) 118: 587, 1988.
Allyn R., Bernstein R., Chynn K.Y., Kourides I.A. Reduction in size of a thyrotropin and gonadotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). J. Clin. Endocrinol. Metab. 74: 690, 1992.
Harris R.I., Schatz N.J., Gennarelli T., Savino P.J., Cobbs W.H., Snyder P.J. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery. J. Clin. Endocrinol. Metab. 56: 1288, 1983.
White M.C., Daniels M., Newland P., Thompson C.J., Cook D., Dewar J., Perry R., Jewitt R., Mathias D., Murdoch A.P., Kendall-Taylor P. LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas. Clin. Endocrinol. (Oxf.) 32: 681, 1990.
Snyder P.J., Muzyka R., Johnson J., Utiger R.D. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone responses in men who have pituitary adenomas and FSH hypersecretion. J. Clin. Endocrinol. Metab. 51: 744, 1980.
Demura R., Jibiki K., Kubo O., Odagiri E., Demura H., Kitamura K., Shizume K. The significance of alpha-subunit as a tumor marker for gonadotropin-producing pituitary adenomas. J. Clin. Endocrinol. Metab. 63: 564, 1986.
Klibanski A., Alexander J.M., Bikkal H.A., Hsu D.W., Swearigen B., Zervas N.T. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro. J. Clin. Endocrinol. Metab. 73: 1248, 1991.
Samuels M.H., Henry P., Ridgway E.C. Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. J. Clin. Endocrinol. Metab. 74: 217, 1992.
Galway A.B., Hsueh A.J.W., Daneshdoost L., Zhou M., Pavlou S.N., Snyder P.J. Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 71: 907, 1990.
Samuels M.H., Henry P., Kleinschmidt-Demasters B.K., Lillehei K., Ridgway E.C. Pulsatile glycoprotein hormone secretion in glycoprotein-producing pituitary tumors. J. Clin. Endocrinol. Metab. 73: 1281, 1991.
Beck-Peccoz P., Bassetti M., Spada A., Medri G., Arosio M., Giannastasio G., Faglia G. Glycoprotein hormorne alpha-subunit response to growth hormone-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell. J. Clin. Endocrinol. Metab. 61: 541, 1985.
Ishibashi M., Yamaji T., Takaku F., Teramoto A., Fukushima T. Secretion of glycoprotein hormone α-subunit by pituitary tumors. J. Clin. Endocrinol. Metab. 64: 1187, 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blanco, C., Lucas, T., Alcañiz, J. et al. Usefulness of thyrotropin-releasing hormone test, SMS 201–995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas. J Endocrinol Invest 17, 99–104 (1994). https://doi.org/10.1007/BF03347693
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347693